TickerTalks
Browse all tickers →
TickerTalks›$PAVS
PAPAVS

Paranovus Entertainment Technology Ltd.

$PAVS·$4M·Medical - Pharmaceuticals·Healthcare
$4.03+1.0%YTD-99.9%1Y-100.0%
Price updated 6h ago·X counts updated 3d ago
PAPAVS
$PAVSParanovus Entertainment Technology Ltd.
$4.03+1.00%39 posts1×
AI analysisFundamentalsVoices on X
Loading…

On X

The complete picture of $PAVS on X — how loud the conversation is right now, how it has trended over the last two weeks, and which way the crowd is leaning.

39X posts · last 7 days
Sep 13Sep 27
Chatter Meter
1×
QuietNormal · 1×Loud

How loud $PAVS's conversation on X is versus its own normal — 1× is typical, higher means busier. Right now it's about its usual level.

Bullish sentimentAI analysisGenerated by AI from underlying data35 posts analyzed · as of 2026-08-13

Paranovus spikes 40-150% intraday as a low-float Chinese microcap runner, with users citing sub-1M float, 6-K filing overnight, ascending-triangle break above $10 and target ranges of $12-16. Small-cap traders celebrate 30-49% gains from premarket alerts, grouping it with CLRO, WYHG, LBGJ and YXT as pump-and-dump China low-floater plays.

Read what X is saying about $PAVS

  • Bullish vs bearish call — with the AI summary of the day's posts
  • Divergence flag when the top-engagement posts argue the other side
  • How loud the conversation is versus this ticker's own normal
Free, forever. No credit card.

AI verdictAI analysisGenerated by AI from underlying data

TickerTalks' own read on what's driving $PAVS — fundamentals, momentum, or an event — and whether it agrees with the X crowd.

Broken storySelling offAI verdict · as of 2026-09-30

Falling on heavy selling — points lower unless it turns around.

Paranovus running 40-150% intraday as a low-float China microcap — with a 1-for-100 reverse split just announced.

Paranovus Entertainment Technology Limited is a small-cap Chinese-listed name that has just announced a 1-for-100 reverse share split — the specific corporate action that's a massive red flag combined with the current pump pattern.

Why the trajectory is breaking down:

  • A 1-for-100 reverse share split announcement is one of the strongest possible negative signals at a small-cap — reverse splits at this ratio typically signal a company trying to maintain minimum listing requirements while its underlying share value collapses, and the parabolic 40-150% intraday moves plus sub-1M float pattern is textbook low-float pump ahead of the split-adjusted-price-collapse mechanic.
  • The corpus explicitly groups PAVS with CLRO/WYHG/LBGJ/YXT as pump-and-dump China low-floater plays — that's honest self-recognition of the cohort dynamics, and no insider events on the file means no positive management signal to counter the pump-and-dump pattern.

A specific stabilization post-reverse-split with real fundamental developments would be required to break the trajectory — but at PAVS's current cap size and with the reverse-split coming, the mechanical path is toward further distribution unless the underlying business changes materially.

Differs from X sentimentThe bullish 40-150% intraday move and target ranges are honestly speculative micro-cap trading talk, but the 1-for-100 reverse split announcement in the news feed is the specific corporate-action signal that historically caps these pump patterns at the top — the celebration is happening at the wrong end of the setup.

What to watch: 1-for-100 reverse split execution and post-split price action, any fundamental business-model change or acquisition announcement, dilutive raise announcements, and SEC/exchange-listing actions — a stable post-split price plus real business change would break the trajectory; the mechanical path is further distribution otherwise.

Read the AI verdict on $PAVS

  • One-line verdict on what's driving the move — fundamentals, momentum, both, or an event
  • Next dated catalyst when there is one (earnings, deal closing, activist clock)
  • Whether TickerTalks' read agrees with or diverges from the X crowd
Free, forever. No credit card.

What it does

Plain-English summary of the business — what they sell and how they make money.

AI-powered gaming and entertainment app company, formerly Happiness Development Group, focused on AI-driven consumer applications.

Industry overviewAI analysisGenerated by AI from underlying data

Where Medical - Pharmaceuticals sits in its cycle right now — and what that implies for $PAVS.

Medical - Pharmaceuticals · Healthcare

No material change from last week — Established-reimbursement specialty pharma is the defensive anchor: CORT earns EU CHMP positive opinion for Lifyorli (relacorilant) and grows to mid-cap on institutional support.

What this means for $PAVS

Neutral — AI-powered gaming and entertainment app company, formerly Happiness Development Group, focused on AI-driven consumer applications.

Industry benchmark

4-name peer basket
+85.3%YTD
+66.7%1Y

Fundamentals & catalyst

Profitability, valuation, and the next earnings event — at a glance, with rule-of-thumb signals.

Key ratios

P/E
-0.7How much investors are paying per dollar of profit the company actually earned in the last 12 months. Lower means the stock looks cheaper relative to earnings.~15–25 is typical for the S&P 500; high-growth names trade 30+; hyper-growth or speculative can be 100+ or negative.
ROIC
-5.2%What percentage return the business earns on every dollar of capital (equity + debt) deployed in operations. The cleanest measure of business quality.Above ~15% is high-quality; consistently above 25% suggests a real moat. Below the company's cost of capital is value-destroying.
Op margin
-14.3%Operating profit (after sales, marketing, R&D, and overhead but before interest and taxes) as a percentage of revenue. The clearest view of how well the underlying business is run.Mature business above 20% is healthy; software businesses can run 30%+; commodity / retail businesses operate in single digits.
FCF yield
-0.5%Free cash flow (operating cash flow minus capex) divided by the company's market cap. The cash-on-cash return you'd get owning the whole business at today's price.Above ~5% is attractive; below ~2% means you're paying up for growth. Capital-light businesses (software) run higher than capital-heavy ones (utilities).
P/S
30.1Same idea as P/E but per dollar of revenue. Useful for companies that aren't profitable yet, where P/E is meaningless.Under ~2 is cheap; software / SaaS often runs 8–15; well above 20 implies the market is pricing in very high future growth.
ROE
-26.7%Net income as a percentage of shareholders' equity. Similar to ROIC but counts only the equity side.Above 20% is strong, but can be inflated by leverage — a heavily indebted company can show high ROE with weak underlying ROIC.
Gross margin
9.7%Revenue minus the direct cost of producing what was sold, as a percentage of revenue. The first read on whether the product is structurally profitable.Software / SaaS is typically 70%+; consumer goods 30–50%; commodity / hardware businesses can be under 20%.
D/E
0.2Total debt divided by shareholders' equity. Measures how much the business runs on borrowed money versus owner capital.Under 1 is conservative; 1–2 is typical for mature businesses; over 2 is leveraged and more sensitive to interest rates.

Past earnings

QuarterReportedActualEstimateSurprise
Q1 2026Jun 3, 2026$-75.22——
Q3 2025Nov 3, 2025$-0.97——
Q2 2025Aug 15, 2025$-47.52$4080.00-101.2%
Q3 2024Oct 30, 2024$-8.68——
Next earningsFri, Jan 15

Quarterly trend

QuarterRevenueYoYGrossOpEPSFCF
Q2 FY25$12.4M—11.3%-5.1%$-0.97$-159K
Q4 FY24$3K-100.0%-6161%-36992%$-10.17$-1.7M
Q2 FY24$68K-99.6%-264%-1690%$-8.68$-966K
Q4 FY23$0-100.0%——$-39.19$900

Forward consensus

4-year forecast · up to 1 analysts
FYRevenueRangeEPSRangeAnalysts
FY27$72.2M$72.2M – $72.2M$2112000.00$2112000.00 – $2112000.001
FY28$72.2M$72.2M – $72.2M$2112000.00$2112000.00 – $2112000.001
FY29$80.1M$80.1M – $80.1M$840000.00$840000.00 – $840000.001
FY30$88.9M$88.9M – $88.9M$1152000.00$1152000.00 – $1152000.001

Setup & momentum

Volume, range, and moving-average position — the technical setup driving short-term moves.

Right now

Vol vs 30dToday's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.0.4×Today's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.
52w rangeWhere the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.0%Where the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.
vs 50d MALatest close vs the 50-day simple moving average. Positive = short-term trend is up.-20.0%Latest close vs the 50-day simple moving average. Positive = short-term trend is up.
vs 200d MALatest close vs the 200-day simple moving average. Positive = long-term trend is up.-99.4%Latest close vs the 200-day simple moving average. Positive = long-term trend is up.

Float & profile

FloatTiny float · 856K shFree-float shares — the slice of issued stock actually available to trade. Lower buckets squeeze harder on a catalyst.Traded today0.9% of floatToday's volume as a percent of the free float. Above 5% on a single day is unusually high turnover for the available share count.β-0.145-year weekly beta vs the S&P 500. Above 1.5 means the stock typically moves more than the index; below 0.8 moves less.

SEC filings

Material 8-K, 13D, S-3, and 424B5 events from the last 180 days — the filings that actually move the price.

Recent material filings

424B5Prospectus supplement (offering)Jun 16424B5
AI summary

Paravision filed a 424B5 for an offering of 9,300,000 Class A ordinary shares at $0.20/share plus 40,700,000 pre-funded warrants ($0.0001 exercise price), for a combined approximately $10M gross. Deeply dilutive micro-cap offering at $0.20/share.

424B5Prospectus supplement (offering)Jun 9424B5
AI summary

Paravision filed a 424B5 for an ATM prospectus allowing sales of Class A ordinary shares up to approximately $195M aggregate through AC Sunshine as sales agent; at a prior price of $0.20/share, this represents potential for very large dilution if fully utilized. Massive ATM facility relative to share price; extreme dilution potential.

3New insider — initial holdingsApr 63
+ 10 other (8 6-Ks · 1 20-F · 1 NT 20-F) in window

Recent news

Latest headlines from major outlets, sourced and timestamped — context for whatever just moved.

Paranovus Entertainment Technology Limited Announces 1-For-100 Reverse Share Splitaccessnewswire.com·98d ago

More in Medical - Pharmaceuticals

Peers in the same group — one click to compare setups, fundamentals, and chatter.

$LQDA$CORT$SDEV$RPRX$KNSA
Voices on X · last 7 days

No standout posts about $PAVS on X in the last 7 days.

TickerTalks is a research tool, not financial advice. We surface social-attention data; we do not make stock recommendations. Past attention is not predictive of future price movements.

PrivacyTermsSupport